Clinical Pathway for Evaluation/Management of Neonates Presenting
with Findings of Perinatal Urinary Tract Dilation
PRENATAL Ultrasound Risk Stratification
for Postnatal Intervention
for Postnatal Intervention
Low Risk (A1)
- ≥ 28 weeks AP RPD 7 to < 10 mm
- or
- 16-27 weeks AP RPD 4 to 6.9 mm and no imaging/measurements ≥ 28 weeks
- or
- Central calyceal dilation with all other US findings normal
Increased Risk (A2-3)
- ≥ 28 weeks AP RPD ≥ 10 mm
- or
- 16-27 weeks AP RPD ≥ 7 mm
- or
- Any additional abnormal ultrasound finding (except central calyceal dilation)
Obtain POSTNATAL US per recommendations
POSTNATAL Ultrasound Risk Stratification
Low Risk (P1)
- AP RPD 10 to < 15 mm
- and/or
- Central calyceal dilation with all other US findings normal
Intermediate Risk (P2)
- AP RPD ≥ 15 mm
- and/or
- Any of the following:
- Peripheral calyceal dilation
- Abnormal ureters
High Risk (P3)
- AP RPD ≥ 15 mm
- and/or
- Any of the following:
- Abnormal parenchymal thickness
- Abnormal parenchymal appearance
- Abnormal bladder
- Abnormal urethra
Discharge Planning Considerations
If ultrasound is obtained at outside hospital, obtain CD of images and bring to PCP and/or urology follow-up.
Reinforce importance of continued antibiotics (if prescribed) until follow-up with urology to avoid complications.
Inform family to refill and continue amoxicillin every 2 weeks until follow-up with PCP or urology.
CHOP Urology strongly recommends obtaining VCUG at CHOP to ensure reduced radiation exposure and quality images.
Do not discharge patient until imaging findings are resulted.
UTD | Urinary tract dilation |
---|---|
A | Antenatal |
P | Postnatal |
AP RPD | Anterior-posterior renal pelvic diameter |
VCUG | Voiding cystourethrogram |
CeVUS | Contrast-enhanced voiding urosonography |
RBUS | Renal and bladder ultrasound |
MAG 3 | Lasix (nuclear medicine) renal scan |
fMRU | Functional MR urography |
VUR | Vesicoureteral reflux |
UPJ | Ureteropelvic junction |
- Ultrasound Findings of UTD
- Central or peripheral calyceal dilation
- Abnormal parenchymal thickness
- Abnormal parenchymal appearance
- Abnormal ureters
- Abnormal bladder
- Abnormal urethra
Posted: May 2019
Revised: January 2023
Authors: D. Weiss, MD; K. Mckenna, MD; H. Otero, MD; D. Kaiser, CRNP
Revised: January 2023
Authors: D. Weiss, MD; K. Mckenna, MD; H. Otero, MD; D. Kaiser, CRNP
Evidence
- The Society for Fetal Urology Consensus Statement on the Evaluation and Management of Antenatal Hydronephrosis
- The Antenatal Urinary Tract Dilation Classification System Accurately Predicts Severity of Kidney and Urinary Tract Abnormalities
- Society for Fetal Urology Classification vs Urinary Tract Dilation Grading System for Prognostication in Prenatal Hydronephrosis: A Time to Resolution Analysis
- The Association Between Continuous Antibiotic Prophylaxis and UTI from Birth Until Initial Postnatal Imaging Evaluation Among Newborns with Antenatal Hydronephrosis
Related CHOP Programs